新闻Chris Adams left Cell Genesys, Inc. on Jan 1st '10.Cydan’s management team will also include Chris Adams as chief business officer, former chief business officer of FoldRx (acquired by Pfizer in 2010); James McArthur, chief scientific officer and former senior R&D executive at Synovex, Phylogix and Cell Genesys; and Deborah Geraghty, vice president of project and portfolio development, and a former senior portfolio management executive at Aileron Therapeutics and Infinity Pharmaceuticals.
